275 Grove St., Suite 101C, Newton, MA 02466
+1 617 454 9300
2520 Meridian Parkway, Research Triangle Park, Suite 200, Durham, NC 27713
+1 919 544 3170
© 2000-2021. Parexel International Corporation.
The cell and gene therapy (CGT) era promises to make life-changing drugs more accessible to patients worldwide. Yet, only a few have gained approval to date. Parexel’s consulting experts, including former regulators provide unique insight into the four most significant challenges companies need to address to accelerate product development.
Pandemic preparedness: Investing in the future of infectious disease vaccine development
What you need to know about accelerated pathways
The evolving role of real-world evidence (RWE)
Learn more about Parexel Regulatory & Access Consulting services